The Usefulness of Traditional Antibodies for the Diagnosis of Sjogren’s Syndrome
Dr Melchor Rodrigo, MD*
Corresponding Author: Dr Melchor Rodrigo, MD, Professor of Neurology, Buenos Aires, Argentina
Copy Right: © 2022 Dr Melchor Rodrigo, MD, This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received Date: March 08, 2022
Published Date: May 10, 2022
It is classically known that Sjogren’s Syndrome has two specific antibodies associated with it, Anti Ro SSA and Anti LA SSB. But exactly how useful are they? As research advances, we are seeing that these two antibodies are not obsolete but are indeed unreliable. It is known for example that those patients with positive antibodies have a higher incidence of lymphoma.
But are they really useful in the diagnosis of the disease? As it is well known, Sjogren’s disease compromises practically every organ in the body. We also know that these antibodies are very specific but not very sensitive.
So, the question is, how many Sjogren’s Disease cases are never diagnosed? The American-European Consensus Criteria for Sjogren’s Disease includes the presence of at least one of these two antibodies. It has as exclusion criteria: past head and neck radiation treatment, Hepatitis C infection, AIDS, preexisting lymphoma, Sarcoidosis, graft vs host disease, current use of anticholinergic drugs.
Ocular Symptoms (at least one)
In patients with another well-defined major connective tissue disease, the presence of one symptom (I or II) plus 2 of the 3 objective criteria (III, IV and V) is indicative of secondary SS.
Something to take into account: the histopathological analysis is not only uncomfortable for the patient, but it may fail to show the classical focal lymphocytic sialadenitis with a focus score ≥1 (ie, "positive" lip biopsy), because these findings may be located somewhere else on the lip.
Something else to remember: salivary scintigraphy means radiation exposure.
The actual definite diagnosis of Sjogren’s Disease can be made by simply testing for alterations in the
ALDH3A2 gene.
To evaluate the possibility of an easier path to diagnosis, taking into account the low sensitivity of the regularly tested antibodies, and the possible errors regarding histopathological analysis, as well as radiation exposure.
gene (5 volunteers).
We may have a shortcut for the diagnosis of this terrible disease, that may even make histopathological analysis and nuclear medicine tests unnecessary. We need more experience in the usefulness of testing for alterations in the ALDH3A2 gene.
References